• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国儿童心脏移植术后院内死亡率的风险预测模型。

A risk-prediction model for in-hospital mortality after heart transplantation in US children.

机构信息

Department of Cardiology, Children's Hospital, Boston, MA, USA.

出版信息

Am J Transplant. 2012 May;12(5):1240-8. doi: 10.1111/j.1600-6143.2011.03932.x. Epub 2012 Feb 2.

DOI:10.1111/j.1600-6143.2011.03932.x
PMID:22300640
Abstract

We sought to develop and validate a quantitative risk-prediction model for predicting the risk of posttransplant in-hospital mortality in pediatric heart transplantation (HT). Children <18 years of age who underwent primary HT in the United States during 1999-2008 (n = 2707) were identified using Organ Procurement and Transplant Network data. A risk-prediction model was developed using two-thirds of the cohort (random sample), internally validated in the remaining one-third, and independently validated in a cohort of 338 children transplanted during 2009-2010. The best predictive model had four categorical variables: hemodynamic support (ECMO, ventilator support, VAD support vs. medical therapy), cardiac diagnosis (repaired congenital heart disease [CHD], unrepaired CHD vs. cardiomyopathy), renal dysfunction (severe, mild-moderate vs. normal) and total bilirubin (≥ 2.0, 0.6 to <2.0 vs. <0.6 mg/dL). The C-statistic (0.78) and the Hosmer-Lemeshow goodness-of-fit (p = 0.89) in the model-development cohort were replicated in the internal validation and independent validation cohorts (C-statistic 0.75, 0.81 and the Hosmer-Lemeshow goodness-of-fit p = 0.49, 0.53, respectively) suggesting acceptable prediction for posttransplant in-hospital mortality. We conclude that this risk-prediction model using four factors at the time of transplant has good prediction characteristics for posttransplant in-hospital mortality in children and may be useful to guide decision-making around patient listing for transplant and timing of mechanical support.

摘要

我们旨在开发和验证一种用于预测儿科心脏移植(HT)后院内死亡风险的定量风险预测模型。使用器官采购与移植网络数据,确定了 1999 年至 2008 年期间在美国接受初次 HT 的<18 岁儿童(n=2707)。使用队列的三分之二(随机样本)开发风险预测模型,在其余三分之一中进行内部验证,并在 2009-2010 年接受移植的 338 名儿童队列中进行独立验证。最佳预测模型有四个分类变量:血流动力学支持(ECMO、呼吸机支持、VAD 支持与药物治疗)、心脏诊断(修复型先天性心脏病[CHD]、未修复型 CHD 与心肌病)、肾功能不全(严重、轻度-中度与正常)和总胆红素(≥2.0、0.6 至<2.0 与<0.6mg/dL)。模型开发队列中的 C 统计量(0.78)和 Hosmer-Lemeshow 拟合优度(p=0.89)在内部验证和独立验证队列中得到复制(C 统计量 0.75、0.81 和 Hosmer-Lemeshow 拟合优度 p=0.49、0.53),表明对移植后院内死亡率有可接受的预测。我们得出结论,这种在移植时使用四个因素的风险预测模型对儿童移植后院内死亡率具有良好的预测特征,可能有助于指导患者列入移植名单和机械支持的时机。

相似文献

1
A risk-prediction model for in-hospital mortality after heart transplantation in US children.美国儿童心脏移植术后院内死亡率的风险预测模型。
Am J Transplant. 2012 May;12(5):1240-8. doi: 10.1111/j.1600-6143.2011.03932.x. Epub 2012 Feb 2.
2
Risk prediction for early in-hospital mortality following heart transplantation in the United States.美国心脏移植术后早期院内死亡风险预测。
Circ Heart Fail. 2012 Mar 1;5(2):259-66. doi: 10.1161/CIRCHEARTFAILURE.111.965996. Epub 2012 Feb 3.
3
A Recipient Risk Prediction Tool for Short-term Mortality After Pediatric Heart Transplantation.儿科心脏移植术后短期死亡率的受者风险预测工具。
Transplantation. 2019 Nov;103(11):2434-2439. doi: 10.1097/TP.0000000000002679.
4
Composite risk factors predict survival after transplantation for congenital heart disease.复合危险因素可预测先天性心脏病移植后的生存率。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):888-93. doi: 10.1016/j.jtcvs.2013.06.016. Epub 2013 Jul 22.
5
Center effect on posttransplant survival among currently active United States pediatric heart transplant centers.目前美国儿科心脏移植中心中中心效应对移植后存活率的影响。
Am J Transplant. 2018 Dec;18(12):2914-2923. doi: 10.1111/ajt.14950. Epub 2018 Jun 19.
6
Factors associated with in-hospital mortality in infants undergoing heart transplantation in the United States.美国婴儿心脏移植术后院内死亡的相关因素。
J Thorac Cardiovasc Surg. 2011 Feb;141(2):531-6, 536.e1. doi: 10.1016/j.jtcvs.2010.10.025.
7
Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA.美国等待心脏移植婴儿的死亡率及其危险因素。
J Heart Lung Transplant. 2009 Dec;28(12):1292-8. doi: 10.1016/j.healun.2009.06.013. Epub 2009 Sep 26.
8
Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery?欧洲心脏手术风险评估系统(EuroSCORE)能否预测心脏手术后的住院时间及特定术后并发症?
Eur J Cardiothorac Surg. 2005 Jan;27(1):128-33. doi: 10.1016/j.ejcts.2004.09.020.
9
Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A.美国儿科心脏移植术后药物不依从对生存的影响
J Heart Lung Transplant. 2013 Sep;32(9):881-8. doi: 10.1016/j.healun.2013.03.008. Epub 2013 Jun 4.
10
Transplant Outcomes for Congenital Heart Disease Patients Bridged With a Ventricular Assist Device.先天性心脏病患者使用心室辅助装置桥接的移植结果。
Ann Thorac Surg. 2018 Aug;106(2):588-594. doi: 10.1016/j.athoracsur.2018.03.060. Epub 2018 Apr 30.

引用本文的文献

1
Risk factors affecting mortality in pediatric heart transplantation: A comprehensive review of pre- and post-transplant contributors.影响小儿心脏移植死亡率的危险因素:移植前和移植后影响因素的综合综述
JHLT Open. 2025 May 31;9:100309. doi: 10.1016/j.jhlto.2025.100309. eCollection 2025 Aug.
2
Pulmonary Artery Size as a Predictor of Early Post-operative Pediatric and Congenital Heart Transplant Outcomes.肺动脉大小作为小儿和先天性心脏移植术后早期预后的预测指标
Pediatr Cardiol. 2025 Mar 27. doi: 10.1007/s00246-025-03839-z.
3
Tough choices: the experience of family members of critically ill patients participating in ECMO treatment decision-making: a descriptive qualitative study.
艰难的抉择:参与体外膜肺氧合治疗决策的重症患者家庭成员的经历:一项描述性定性研究
BMC Med Inform Decis Mak. 2025 Feb 7;25(1):65. doi: 10.1186/s12911-025-02876-1.
4
The Role of Artificial Intelligence in Prediction, Risk Stratification, and Personalized Treatment Planning for Congenital Heart Diseases.人工智能在先天性心脏病预测、风险分层及个性化治疗规划中的作用
Cureus. 2023 Aug 30;15(8):e44374. doi: 10.7759/cureus.44374. eCollection 2023 Aug.
5
Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.可调节的儿科心室辅助装置的风险因素减少和移植时持续的可调节风险因素的影响。
J Thorac Cardiovasc Surg. 2024 May;167(5):1556-1563.e2. doi: 10.1016/j.jtcvs.2023.06.015. Epub 2023 Jul 5.
6
Racial disparity exists in the utilization and post-transplant survival benefit of ventricular assist device support in children.种族差异存在于儿童心室辅助装置支持的利用和移植后生存获益中。
J Heart Lung Transplant. 2023 May;42(5):585-592. doi: 10.1016/j.healun.2022.12.020. Epub 2022 Dec 28.
7
Palliated Hypoplastic Left Heart Syndrome Patients Experience Superior Waitlist and Comparable Post-Heart Transplant Survival to Non-Single Ventricle Congenital Heart Disease Patients.姑息性左心发育不全综合征患者在等待名单上的情况更佳,且心脏移植后的生存率与非单心室先天性心脏病患者相当。
Semin Thorac Cardiovasc Surg. 2024 Summer;36(2):230-241. doi: 10.1053/j.semtcvs.2022.08.019. Epub 2022 Nov 29.
8
External validation and comparison of risk score models in pediatric heart transplants.儿科心脏移植中风险评分模型的外部验证和比较。
Pediatr Transplant. 2022 May;26(3):e14204. doi: 10.1111/petr.14204. Epub 2021 Dec 8.
9
Rehabilitation in Pediatric Heart Failure and Heart Transplant.小儿心力衰竭与心脏移植的康复治疗
Front Pediatr. 2021 May 19;9:674156. doi: 10.3389/fped.2021.674156. eCollection 2021.
10
Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015.2006 年至 2015 年美国表现优异的儿科心脏移植中心的特点。
JAMA Netw Open. 2020 Nov 2;3(11):e2023515. doi: 10.1001/jamanetworkopen.2020.23515.